Platelet adhesion in hypertension: Application of a novel assay of platelet adhesion

References

• Lip GYH. Hypertension, platelets, and the endothelium: the 'thrombotic paradox' of hypertension (or 'Birmingham paradox') revisited. Hypertension. 2003;41:199–200.
   PubMed Web of Science ®Google Scholar
• Felmeden DC, Spencer CG, Chung NA, Belgore FM, Blann AD, Beevers DG, et al. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). Am J Cardiol. 2003;92:400–5.
   PubMed Web of Science ®Google Scholar
• Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, et al. Determinants of platelet activation in human essential hypertension. Hypertension. 2004;43:64–70.
   PubMed Web of Science ®Google Scholar
• Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension. 2003;41:211–7.
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol. 2001;38Suppl 2:S11–S14.
   Google Scholar
• Gupta S, Gupta VK, Dhamija RK, Kela AK. Platelet aggregation patterns in normotensive and hypertensive subjects. Indian J Physiol Pharmacol. 2002;46:379–82.
   PubMedGoogle Scholar
• Fornitz GG. Platelet function and fibrinolytic activity in borderline and mild hypertension. The influence of age, exercise, smoking and antihypertensive therapy. Dan Med Bull. 2002;49:210–26.
   Google Scholar
• Blann AD, Lip GYH, Islim IF, Beevers DG. Evidence of platelet activation in hypertension. J Hum Hypertens. 1997;11:607–9.
   PubMed Web of Science ®Google Scholar
• Lemne C, Vesterqvist 0, Egberg N, Green K, Jogestrand T, de Faire U. Platelet activation and prostacyclin release in essential hypertension. Prostaglandins. 1992;44:219–35.
   Google Scholar
• Ni H, Freedman J. Platelets in hemostasis and thrombosis: role of integrins and their ligands. Transfus Apheresis Sci. 2003;28:257–64.
   PubMed Web of Science ®Google Scholar
• Karnath S, Blann AD, Lip GYH. Platelet activation: assess-ment and quantification. Eur Heart J. 2001;22:1561–71.
   Google Scholar
• Semenov AV, Romanov YA, Loktionova SA, Tikhomirov OY, Khachikian MV, Vasil'ev SA. Production of soluble P-selectin by platelets and endothelial cells. Biochemistry (Mosc). 1999;64:1326–35.
   Google Scholar
• Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma jj, et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost. 1997;77:1081–85.
   PubMed Web of Science ®Google Scholar
• Caine G, Nadar S, Spooner D, Stonelake P, Lip GYH, Blann A. Platelet adhesion in breast cancer: development and application of a novel assay. Blood Coagul Fibrinolysis. 2004;15:513–8.
   PubMed Web of Science ®Google Scholar
• Karnath S, Blann AD, Caine GJ, Gurney D, Chin BS, Lip GY. Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrilla-tion. Stroke. 2002;33:1237–42.
   PubMed Web of Science ®Google Scholar
• Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, et al. Study of platelet adhesion in patients with uncomplicated hypertension. J Hypertens. 1996;14:1215–21.
   PubMed Web of Science ®Google Scholar
• Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, et al. A colorimetric method for the measurement of platelet adhesion in mcrotiter plates. Anal Biochem. 1994;216:444–50.
   PubMed Web of Science ®Google Scholar
• Marietta M, Castelli I, Piccinini F, Neri I, Bertesi M, Facchinetti F, et al. The PFA-100 system for the assessment of platelet function in normotensive and hypertensive pregnancies. Clin Lab Haematol. 2001;23:131–4.
   PubMedGoogle Scholar
• Blann AD, Nadar S, Lip GYH. Pharmacological modulation of platelet function in hypertension. Hypertension. 2003;42:1–7.
   PubMed Web of Science ®Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755–62.
   PubMed Web of Science ®Google Scholar